Overview

Zonisamide for Fibromyalgia & Migraine

Status:
Withdrawn
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Patients with fibromyalgia & migraine are randomized to receive zonisamide or placebo.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
Eisai Inc.
Treatments:
Zonisamide